Kay Sharma, Chief Medical Officer(CMO) at iCardioOncology, shared a post on LinkedIn:
“It is a profound honor for SanMed iCardioOncology to take part this year’s China Anti-Cancer Association – 2025 China Conference on Holistic Integrative Oncology (CCHIO), one of the largest, highly prestegious and transformative global event redefining the future of cancer care.
By hosting the Cardio-Oncology Sub-Forum and the new national program for ‘Advancing Multi-Organ Protection Competency in Cancer Care’, we bring together leading voices, bridging multi-disciplinary science, innovation, and clinical expertise.
I am proud together with Sandra Wang in leading this initiative, uniting top hospitals and national leaders under one shared vision. The forum, highlights the essential shift in oncology: moving from a single-organ focus to a holistic, multi-organ perspective. With cancer therapies becoming increasingly powerful and complex, protecting not only the heart but all vital organs is key to improving patient outcomes by precision treatment, managing co-morbidities, increasing survivorship and quality of life.
It is a personal honor for me to serve on the panels of both sessions, representing International Cardio-Oncology Society, and contributing to these critical conversations on multi-organ protection and patient-centered cancer care.
I look forward to the future of integrative oncology, and in translating best practices into actionable strategies for patients worldwide.
Location: 2025 China Conference on Holistic Integrative Oncology (CCHIO)
Date: November 6–9, 2025 | Kunming, Yunnan Province, China”
More posts featuring China Anti-Cancer Association.
